FNF: $41 Price, $61 Target, and No Insiders Buying
Fidelity National Financial filed a Regulation FD investor disclosure on September 15 while its stock continues to trade at $41.42 — against a consensus analyst price target of $61.40 — at just 7.2 ti
FNF: $41 Price, $61 Target, and No Insiders Buying
NEW YORK, September 27 —
Even as Fidelity National Financial, Inc. (FNF) posted a 5.3% earnings beat last quarter, the stock trades at $41.42, nearly $20 below the $61.40 analyst consensus at just 7.2 times forward earnings. A September investor disclosure hasn't closed the gap; either the discount is deep value, or the market sees structural earnings risk no quarterly print can resolve.
- TTM revenue of $15.35B grew 10.5% year-over-year; gross margin is 54.0%.
- TTM free cash flow of $3.59B against an $11.11B market cap implies a 3.1 times price-to-FCF multiple.
- Four consecutive EPS surprises, oldest to most recent: +14.8%, -6.0%, -14.7%, +5.3%.
The Cash the Market Won't Price
FNF runs through two economic engines: the Title segment, which provides title insurance and escrow to real estate buyers and mortgage lenders, and F&G, which issues annuities, indexed life insurance, and pension risk transfer solutions targeting retirement savers and institutional clients. Together they generated $15.35 billion in trailing revenue, up 10.5% year-over-year, and threw off $3.59 billion in free cash flow against an $11.11 billion market cap, implying a price-to-FCF of 3.1 times. Cash of $4.02 billion against $4.78 billion in total debt is not alarming. Institutional investors hold 84.9% of shares; the discount holds despite informed ownership, not because of ignorance.
Why One Good Quarter Isn't Enough
When FNF posted $0.93 against a $1.09 consensus estimate two quarters ago, a 14.7% miss that was the deepest shortfall in the trailing four-quarter window, it showed why analysts struggle to underwrite this business. That miss followed a 6.0% shortfall the quarter prior; the most recently reported $1.39 EPS, beating the $1.32 consensus, snapped the run. Four quarters ago the pattern reversed: a 14.8% beat on $1.63 actual versus $1.42 consensus, showing the variance is structural, tied to rate-cycle swings in title insurance volumes rather than management execution.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| FNF | $11.1B | 7.2x | -28.2% |
| FAF | $6.8B | 9.0x | +3.7% |
| FIS | $18.3B | 5.3x | -46.2% |
| ORI | $9.1B | 11.4x | -9.7% |
| STC | $1.8B | 8.1x | -19.6% |
| UNM | $14.6B | 9.7x | +18.9% |
Title Volumes Are the Deciding Number
FNF filed a Regulation FD disclosure on September 15, per SEC filings, an investor outreach that has not yet moved the stock toward the $61.40 consensus. Company insiders hold 5.7% of shares against 84.9% institutional, meaning informed holders already have the position; the question is whether the next rate cycle move confirms the FCF screen or validates the market's structural skepticism. Title segment revenue in the next reported quarter is the specific number that decides: if volumes keep recovering alongside the recent EPS beat, the discount case weakens; if title revenue stalls, the bear case holds. Stress-test the valuation inputs here. Run the free Fidelity National Financial, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Fidelity National Financial filed a Regulation FD investor disclosure on September 15 while its stock continues to trade at $41.42 — against a consensus analyst price target of $61.40 — at just 7.2 times forward earnings. The gap between what analysts think the stock is worth and what the market will pay has persisted through an earnings beat, 10.5% revenue growth, and now a formal investor outreach event.